(Q36226056)

English

Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study (English)

1 reference

Europe PubMed Central

12 August 2017

0 references

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

author name string

Christopher I Li

1

1 reference

Europe PubMed Central

12 August 2017

Justin E Mirus

2

1 reference

Europe PubMed Central

12 August 2017

Yuzheng Zhang

3

1 reference

Europe PubMed Central

12 August 2017

Arturo B Ramirez

4

1 reference

Europe PubMed Central

12 August 2017

Jon J Ladd

5

1 reference

Europe PubMed Central

12 August 2017

Ross L Prentice

6

1 reference

Europe PubMed Central

12 August 2017

Martin W McIntosh

7

1 reference

Europe PubMed Central

12 August 2017

Samir M Hanash

8

1 reference

Europe PubMed Central

12 August 2017

Paul D Lampe

9

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

19 August 2012

1 reference

Europe PubMed Central

12 August 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

12 August 2017

135

1 reference

Europe PubMed Central

12 August 2017

2

1 reference

Europe PubMed Central

12 August 2017

611-618

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1007/s10549-012-2204-4

0 references

Dissecting the heterogeneity of triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Use of a single-chain antibody library for ovarian cancer biomarker discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Screening for breast cancer: an update for the U.S. Preventive Services Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Use of high density antibody arrays to validate and discover cancer serum biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Basal-like breast cancer: a critical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Normalization of cDNA microarray data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

The Women's Health Initiative recruitment methods and results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

1 October 2017

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

29 June 2018

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

29 June 2018

A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

29 June 2018

Ephrin A5 expression promotes invasion and transformation of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2204-4

21 January 2018

Impact of triple negative phenotype on breast cancer prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2204-4

21 January 2018

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2204-4

21 January 2018

Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2204-4

21 January 2018

Fas/Fas-ligand expressions in primary breast cancer are significant predictors of its skeletal spread.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3439142

22 September 2018

Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22903690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas and Fas ligand as prognostic factors in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22903690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22903690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10549-012-2204-4

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36226056&oldid=1989948215"